XML 57 R34.htm IDEA: XBRL DOCUMENT v3.24.1
Stock Options (Tables)
12 Months Ended
Dec. 31, 2023
Stock Options [Abstract]  
Schedule of Stock Option Activity The Company uses the Black-Scholes option pricing model to estimate the fair value of stock options. In applying the Black-Scholes option pricing model, the Company used the following assumptions in 2023:
Expected Volatility     72.4% - 73.8%  
Expected Dividend Yield     0%  
Expected Life (Term)     5.77 - 6.25 Years  
Risk-free Rate     4.26% - 4.66%  
Schedule of Stock Option Activity The following table summarizes the Company’s stock option activity for the year ended December 31, 2023 and 2022:
   Options   Weighted-average
Exercise Price per
Option
   Weighted-average Remaining
Contractual Term
(Years)
   Aggregate
Intrinsic Value
 
Oustanding at December 31, 2022   263,000   $1.25    1.01   $
          -
 
Granted   2,085,034   $2.39    9.8    
 
 
Terminated   (380,300)  $1.60    n/a    
 
 
Outstanding at December 31, 2023   1,967,734   $2.38    9.8    
 
 
Exercisable and vested at December 31, 2023   907,262   $2.40    9.8   $
-
 
Schedule of Stock Options Activity for Non-Vested Options The weighted average grant date fair value of option activity during the year are as follows:
   Shares  

Weighted
Average Grant
Date Fair Value

 
Unvested balance at December 31, 2022        
Granted   2,085,034   $1.61 
Vested   (907,262)  $1.60 
Forfeited   (117,300)  $1.66 
Unvested balance at December 31, 2023   1,060,472   $1.62 
Schedule of Stock Based Compensation Expense Total stock-based compensation expense associated with stock options was classified as follows on the statement of operations for the years ended December 31:
   2023   2022 
Research and development expense  $156   $
   -
 
Sales and marketing expense   63    
-
 
General and administrative expense   1,356    
-
 
Total stock-based compensation expense  $1,575   $
-